Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
Cited by 166
Related Papers
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
|JAMA Oncology|2023|822
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
|Signal Transduction and Targeted Therapy|2022|218
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
|Nature Microbiology|2022|101
Characterization of distinct circular RNA signatures in solid tumors
|Molecular Cancer|2022|84